Lv6
3150 积分 2020-09-19 加入
Iridium and B(C6F5)3 co-catalyzed chemoselective deoxygenative reduction of tertiary amides: application to the efficient synthesis and late-stage modification of pharmaceuticals
2天前
已完结
Discovery of novel 1,2,3-triazole arylamide derivatives bearing dithiocarbamate moiety as dual inhibitors of tubulin and LSD1 with potent anticancer activity
4天前
已完结
USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy
5天前
已完结
Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer
5天前
已完结
BET inhibitors: an updated patent review (2018–2021)
7天前
已完结
TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapy
8天前
已完结
Past, present and future of drug conjugates for cancer therapy
9天前
已完结
Advancing targeted protein degradation for cancer therapy
12天前
已完结
An updated patent review of BRD4 degraders
20天前
已完结
Enantioselective Dihydroxylation of Alkenes Catalyzed by 1,4‐Bis(9‐O‐dihydroquinidinyl)phthalazine‐Modified Binaphthyl–Osmium Nanoparticles
21天前
已完结
皖公网安备34019202002308
